{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:54:38Z","timestamp":1789181678864,"version":"build-2803163510"},"reference-count":45,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Craniopharyngioma is a benign brain tumor with frequent local recurrence or progression after treatment. GH replacement therapy (GHRT) is prescribed in children with GH deficiency resulting from childhood-onset craniopharyngioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether a shorter delay of GHRT initiation after childhood-onset craniopharyngioma completion therapy increased the risk of a new event (progression or recurrence).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective, observational, monocenter study. We compared a cohort of 71 childhood-onset patients with craniopharyngiomas treated with recombinant human GH (rhGH). Twenty-seven patients were treated with rhGH at least 12 months after craniopharyngioma treatment (&amp;gt;12-month group) and 44 patients before 12 months (&amp;lt;12-month group), among which 29 patients were treated between 6 and 12 months (6-12 month group). The main outcome was the risk of tumor new event (progression of residual tumor or tumor recurrence after complete resection) after primary treatment in the &amp;gt;12-month group and in the &amp;lt;12 month or in the 6- to 12-month group patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the &amp;gt;12-month group, the 2- and 5-year event-free survivals were respectively 81.5% (95% CI, 61.1-91.9) and 69.4% (95% CI, 47.9-83.4) compared with 72.2% (95% CI, 56.3-83.1) and 69.8% (95% CI, 53.8-81.2) in the &amp;lt;12-month group. The 2- and 5-year event-free survivals were the same in the 6- to 12-month group (72.4%; 95% CI, 52.4-85.1). By log-rank test, the event-free survival was not different between groups (P = .98 and P = .91).<\/jats:p>\n                    <jats:p>The median time for event was not statistically different.<\/jats:p>\n                    <jats:p>In univariate and multivariate analysis, the risk of craniopharyngioma new event was not associated with the GHRT time delay after craniopharyngioma treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No association was found between GHRT time delay after childhood-onset craniopharyngioma treatment and an increased risk of recurrence or tumor progression, suggesting GH replacement therapy can be initiated 6 months after last treatment for craniopharyngiomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad079","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T02:52:02Z","timestamp":1676515922000},"page":"1929-1936","source":"Crossref","is-referenced-by-count":15,"title":["GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-156X","authenticated-orcid":false,"given":"Adrien","family":"Nguyen Quoc","sequence":"first","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"},{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e9vin","family":"Beccaria","sequence":"additional","affiliation":[{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"Department of Pediatric Neurosurgery, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gonz\u00e1lez Brice\u00f1o","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Pinto","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinane","family":"Samara-Boustani","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Stoupa","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"},{"name":"Cochin Institute, INSERM U1016 , 75014 Paris , France"},{"name":"IMAGINE Institute Affiliate, INSERM U1163 , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Beltrand","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"},{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"Cochin Institute, INSERM U1016 , 75014 Paris , France"},{"name":"IMAGINE Institute Affiliate, INSERM U1163 , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Besan\u00e7on","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Thalassinos","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Puget","sequence":"additional","affiliation":[{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"Department of Pediatric Neurosurgery, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Blauwblomme","sequence":"additional","affiliation":[{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"Department of Pediatric Neurosurgery, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Alapetite","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department, Curie Institute , 75005 Paris , France"},{"name":"Radiation Department, Proton Center , 94800 Orsay , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bolle","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Gustave Roussy institute , 94800 Villejuif , France"},{"name":"ICPO (Institut Curie \u2013 Centre de Protonth\u00e9rapie d'Orsay) , 94800 Orsay , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Doz","sequence":"additional","affiliation":[{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"SIREDO Center (Care, Innovation, Research in, Children, Adolescent and Young Adults Oncology), Curie Institute , 75005 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Grill","sequence":"additional","affiliation":[{"name":"Child and Adolescent Cancer Department, Gustave Roussy institute , 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dufour","sequence":"additional","affiliation":[{"name":"Child and Adolescent Cancer Department, Gustave Roussy institute , 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bourdeaut","sequence":"additional","affiliation":[{"name":"SIREDO Center (Care, Innovation, Research in, Children, Adolescent and Young Adults Oncology), Curie Institute , 75005 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Abbou","sequence":"additional","affiliation":[{"name":"Child and Adolescent Cancer Department, Gustave Roussy institute , 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Guerrini-Rousseau","sequence":"additional","affiliation":[{"name":"Child and Adolescent Cancer Department, Gustave Roussy institute , 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Leruste","sequence":"additional","affiliation":[{"name":"SIREDO Center (Care, Innovation, Research in, Children, Adolescent and Young Adults Oncology), Curie Institute , 75005 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Brabant","sequence":"additional","affiliation":[{"name":"Department of Functional Explorations, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iphig\u00e9nie","family":"Cavadias","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Viaud","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Boddaert","sequence":"additional","affiliation":[{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"Department of Paediatric Radiology, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"},{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"Cochin Institute, INSERM U1016 , 75014 Paris , France"},{"name":"IMAGINE Institute Affiliate, INSERM U1163 , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulanjalee","family":"Kariyawasam","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology, Gynaecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre , 75015 Paris , France"},{"name":"Faculty of medicine, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris , France"},{"name":"Cochin Institute, INSERM U1016 , 75014 Paris , France"},{"name":"IMAGINE Institute Affiliate, INSERM U1163 , 75015 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"11","key":"2023121400510913800_dgad079-B1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00381-005-1181-x","article-title":"Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution","volume":"21","author":"Rosemberg","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"2023121400510913800_dgad079-B2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023121400510913800_dgad079-B3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3171\/jns.1998.89.4.0547","article-title":"The descriptive epidemiology of craniopharyngioma","volume":"89","author":"Bunin","year":"1998","journal-title":"J Neurosurg"},{"issue":"4","key":"2023121400510913800_dgad079-B4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"2023121400510913800_dgad079-B5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000120853","article-title":"Neuroimaging of childhood craniopharyngioma","volume":"21","author":"Harwood-Nash","year":"1994","journal-title":"Pediatr Neurosurg"},{"issue":"1 Suppl","key":"2023121400510913800_dgad079-B6","first-page":"3","article-title":"Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement","volume":"106","author":"Puget","year":"2007","journal-title":"J Neurosurg"},{"issue":"1","key":"2023121400510913800_dgad079-B7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00381-005-1171-z","article-title":"Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features","volume":"22","author":"Gupta","year":"2006","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"2023121400510913800_dgad079-B8","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.wneu.2019.08.209","article-title":"Recurrence rate and prognostic factors for the adult craniopharyngiomas in long-term follow-up","volume":"133","author":"Park","year":"2020","journal-title":"World Neurosurg"},{"issue":"4","key":"2023121400510913800_dgad079-B9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma\u2013German multicenter study on pre-operative risk factors and quality of life","volume":"213","author":"M\u00fcller","year":"2001","journal-title":"Klin Padiatr"},{"issue":"4","key":"2023121400510913800_dgad079-B10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1469-8749.2004.tb00476.x","article-title":"Outcome of craniopharyngioma in children: long-term complications and quality of life","volume":"46","author":"Poretti","year":"2004","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"2023121400510913800_dgad079-B11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-010-0145-5","article-title":"Late mortality in pediatric patients with craniopharyngioma","volume":"100","author":"Visser","year":"2010","journal-title":"J Neurooncol"},{"issue":"6","key":"2023121400510913800_dgad079-B12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EJE-17-0044","article-title":"Very long-term sequelae of craniopharyngioma","volume":"176","author":"Wijnen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023121400510913800_dgad079-B13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0707","article-title":"Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study","volume":"178","author":"Wijnen","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023121400510913800_dgad079-B14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-17-0387","article-title":"The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up","volume":"178","author":"Wijnen","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023121400510913800_dgad079-B15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jc.2017-01542","article-title":"Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement","volume":"103","author":"Yuen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023121400510913800_dgad079-B16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11102-012-0428-2","article-title":"Mortality and morbidity in adult craniopharyngioma","volume":"16","author":"Erfurth","year":"2013","journal-title":"Pituitary"},{"issue":"2","key":"2023121400510913800_dgad079-B17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/adc.75.2.108","article-title":"Growth and endocrine sequelae of craniopharyngioma","volume":"75","author":"DeVile","year":"1996","journal-title":"Arch Dis Child"},{"issue":"Suppl 1","key":"2023121400510913800_dgad079-B18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000120858","article-title":"The endocrine outcome after surgical removal of craniopharyngiomas","volume":"21","author":"Curtis","year":"1994","journal-title":"Pediatr Neurosurg"},{"issue":"5","key":"2023121400510913800_dgad079-B19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1995.tb02664.x","article-title":"Hypothalamic-pituitary dysfunction in patients with craniopharyngioma","volume":"42","author":"Paja","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023121400510913800_dgad079-B20","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2012-3928","article-title":"Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity","volume":"98","author":"Elowe-Gruau","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023121400510913800_dgad079-B21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-18-0505","article-title":"Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo)","volume":"179","author":"Boekhoff","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023121400510913800_dgad079-B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216927","article-title":"Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG growth study","volume":"14","author":"Rhie","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"2023121400510913800_dgad079-B23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12020-017-1489-9","article-title":"Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007","volume":"59","author":"Heinks","year":"2018","journal-title":"Endocrine"},{"issue":"8","key":"2023121400510913800_dgad079-B24","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1210\/jc.2003-030366","article-title":"Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement","volume":"88","author":"Gleeson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023121400510913800_dgad079-B25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000023133","article-title":"Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996","volume":"49","author":"Price","year":"1998","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2023121400510913800_dgad079-B26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI113296","article-title":"Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production","volume":"81","author":"Cook","year":"1988","journal-title":"J Clin Invest"},{"issue":"6","key":"2023121400510913800_dgad079-B27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/ghir.2000.0171","article-title":"Does the GH\u2013IGF axis play a role in cancer pathogenesis?","volume":"10","author":"Cohen","year":"2000","journal-title":"Growth Horm IGF Res"},{"issue":"2","key":"2023121400510913800_dgad079-B28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2265.2005.02404.x","article-title":"Does growth hormone cause cancer?","volume":"64","author":"Jenkins","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2023121400510913800_dgad079-B29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/MCB.17.3.1595","article-title":"Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt","volume":"17","author":"Kulik","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2023121400510913800_dgad079-B30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023121400510913800_dgad079-B31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3171\/2016.4.PEDS16112","article-title":"Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study","volume":"18","author":"Smith","year":"2016","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"2023121400510913800_dgad079-B32","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1210\/clinem\/dgaa089","article-title":"Growth hormone therapy does not increase the risk of craniopharyngioma and nonfunctioning pituitary adenoma recurrence","volume":"105","author":"Losa","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023121400510913800_dgad079-B33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1530\/EJE-12-0077","article-title":"Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up","volume":"166","author":"Olsson","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023121400510913800_dgad079-B34","doi-asserted-by":"crossref","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023121400510913800_dgad079-B35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","article-title":"Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee","volume":"143","author":"Wilson","year":"2003","journal-title":"J Pediatr"},{"issue":"6","key":"2023121400510913800_dgad079-B36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"2023121400510913800_dgad079-B37","author":"Nguyen Quoc"},{"issue":"3","key":"2023121400510913800_dgad079-B38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1227\/01.NEU.0000372918.68453.5B","article-title":"Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation","volume":"67","author":"Hofmann","year":"2010","journal-title":"Neurosurgery"},{"issue":"1","key":"2023121400510913800_dgad079-B39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jocn.2012.04.014","article-title":"Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R)","volume":"20","author":"Li","year":"2013","journal-title":"J Clin Neurosci"},{"issue":"7","key":"2023121400510913800_dgad079-B40","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma","volume":"89","author":"M\u00fcller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023121400510913800_dgad079-B41","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic\u2013pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023121400510913800_dgad079-B42","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/08035250600577889","article-title":"Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)","volume":"95","author":"Darendeliler","year":"2006","journal-title":"Acta Paediatr"},{"issue":"8-9","key":"2023121400510913800_dgad079-B43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00381-005-1202-9","article-title":"Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital","volume":"21","author":"Tomita","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"2023121400510913800_dgad079-B44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1227\/00006123-198209000-00008","article-title":"Craniopharyngiomas in children","volume":"11","author":"Carmel","year":"1982","journal-title":"Neurosurgery"},{"issue":"1","key":"2023121400510913800_dgad079-B45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.wneu.2017.09.164","article-title":"Physiologic growth hormone replacement therapy and craniopharyngioma recurrence in pediatric patients: a meta-analysis","volume":"109","author":"Alotaibi","year":"2018","journal-title":"World Neurosurg"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad079\/49532496\/dgad079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/1929\/54423733\/dgad079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/1929\/54423733\/dgad079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T20:40:07Z","timestamp":1702500007000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/8\/1929\/7041103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,2,16]]},"published-print":{"date-parts":[[2023,7,14]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad079","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,2,16]]}}}